|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning professional regulation.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Pharmacy Practice Act is amended by changing | ||||||
5 | Section 4 as follows:
| ||||||
6 | (225 ILCS 85/4) (from Ch. 111, par. 4124)
| ||||||
7 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
8 | Sec. 4. Exemptions. Nothing contained in any Section of | ||||||
9 | this Act shall
apply
to, or in any manner interfere with:
| ||||||
10 | (a) the lawful practice of any physician licensed to | ||||||
11 | practice medicine in
all of its branches, dentist, podiatrist,
| ||||||
12 | veterinarian, or therapeutically or diagnostically certified | ||||||
13 | optometrist within
the limits of
his or her license, or prevent | ||||||
14 | him or her from
supplying to his
or her
bona fide patients
such | ||||||
15 | drugs, medicines, or poisons as may seem to him appropriate;
| ||||||
16 | (b) the sale of compressed gases;
| ||||||
17 | (c) the sale of patent or proprietary medicines and | ||||||
18 | household remedies
when sold in original and unbroken packages | ||||||
19 | only, if such patent or
proprietary medicines and household | ||||||
20 | remedies be properly and adequately
labeled as to content and | ||||||
21 | usage and generally considered and accepted
as harmless and | ||||||
22 | nonpoisonous when used according to the directions
on the | ||||||
23 | label, and also do not contain opium or coca leaves, or any
|
| |||||||
| |||||||
1 | compound, salt or derivative thereof, or any drug which, | ||||||
2 | according
to the latest editions of the following authoritative | ||||||
3 | pharmaceutical
treatises and standards, namely, The United | ||||||
4 | States Pharmacopoeia/National
Formulary (USP/NF), the United | ||||||
5 | States Dispensatory, and the Accepted
Dental Remedies of the | ||||||
6 | Council of Dental Therapeutics of the American
Dental | ||||||
7 | Association or any or either of them, in use on the effective
| ||||||
8 | date of this Act, or according to the existing provisions of | ||||||
9 | the Federal
Food, Drug, and Cosmetic Act and Regulations of the | ||||||
10 | Department of Health
and Human Services, Food and Drug | ||||||
11 | Administration, promulgated thereunder
now in effect, is | ||||||
12 | designated, described or considered as a narcotic,
hypnotic, | ||||||
13 | habit forming, dangerous, or poisonous drug;
| ||||||
14 | (d) the sale of poultry and livestock remedies in original | ||||||
15 | and unbroken
packages only, labeled for poultry and livestock | ||||||
16 | medication;
| ||||||
17 | (e) the sale of poisonous substances or mixture of | ||||||
18 | poisonous substances,
in unbroken packages, for nonmedicinal | ||||||
19 | use in the arts or industries
or for insecticide purposes; | ||||||
20 | provided, they are properly and adequately
labeled as to | ||||||
21 | content and such nonmedicinal usage, in conformity
with the | ||||||
22 | provisions of all applicable federal, state and local laws
and | ||||||
23 | regulations promulgated thereunder now in effect relating | ||||||
24 | thereto
and governing the same, and those which are required | ||||||
25 | under such applicable
laws and regulations to be labeled with | ||||||
26 | the word "Poison", are also labeled
with the word "Poison" |
| |||||||
| |||||||
1 | printed
thereon in prominent type and the name of a readily | ||||||
2 | obtainable antidote
with directions for its administration;
| ||||||
3 | (f) the delegation of limited prescriptive authority by a | ||||||
4 | physician
licensed to
practice medicine in all its branches to | ||||||
5 | a physician assistant
under Section 7.5 of the Physician | ||||||
6 | Assistant Practice Act of 1987. This
delegated authority under | ||||||
7 | Section 7.5 of the Physician Assistant Practice Act of 1987 | ||||||
8 | may , but is not required to , include prescription of
controlled | ||||||
9 | substances, as defined in Article II of the
Illinois Controlled | ||||||
10 | Substances Act, in accordance with a written supervision | ||||||
11 | agreement guidelines ; and
| ||||||
12 | (g) The delegation of prescriptive authority by a physician
| ||||||
13 | licensed to practice medicine in all its branches or a licensed | ||||||
14 | podiatrist to an advanced practice
nurse in accordance with a | ||||||
15 | written collaborative
agreement under Sections Section 65-35 | ||||||
16 | and 65-40 of the Nurse Practice Act. This authority, which is | ||||||
17 | delegated under Section 65-40 of the Nurse Practice Act, may | ||||||
18 | but is not required to
include the prescription of Schedule | ||||||
19 | III, IV, or V controlled substances as
defined
in Article II of | ||||||
20 | the Illinois Controlled Substances Act.
| ||||||
21 | (Source: P.A. 95-639, eff. 10-5-07 .)
| ||||||
22 | Section 10. The Physician Assistant Practice Act is amended | ||||||
23 | by changing Sections 4, 7.5, and 21 as follows:
| ||||||
24 | (225 ILCS 95/4) (from Ch. 111, par. 4604)
|
| |||||||
| |||||||
1 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
2 | Sec. 4. In this Act:
| ||||||
3 | 1. "Department" means the Department of Financial and
| ||||||
4 | Professional Regulation.
| ||||||
5 | 2. "Secretary" means the Secretary
of Financial and | ||||||
6 | Professional Regulation.
| ||||||
7 | 3. "Physician assistant" means any person not a physician | ||||||
8 | who has been
certified as a physician assistant by the National | ||||||
9 | Commission on the
Certification of Physician Assistants or | ||||||
10 | equivalent successor agency and
performs procedures under the | ||||||
11 | supervision of a physician as defined in this
Act. A physician | ||||||
12 | assistant may perform such procedures within the
specialty of | ||||||
13 | the supervising physician, except that such physician shall
| ||||||
14 | exercise such direction, supervision and control over such | ||||||
15 | physician
assistants as will assure that patients shall receive | ||||||
16 | quality medical
care. Physician assistants shall be capable of | ||||||
17 | performing a variety of tasks
within the specialty of medical | ||||||
18 | care under the supervision of a physician.
Supervision of the | ||||||
19 | physician assistant shall not be construed to
necessarily | ||||||
20 | require the personal presence of the supervising physician at
| ||||||
21 | all times at the place where services are rendered, as long as | ||||||
22 | there is
communication available for consultation by radio, | ||||||
23 | telephone or
telecommunications within established guidelines | ||||||
24 | as determined by the
physician/physician assistant team. The | ||||||
25 | supervising physician may delegate
tasks and duties to the | ||||||
26 | physician assistant. Delegated tasks or duties
shall be |
| |||||||
| |||||||
1 | consistent with physician assistant education, training, and
| ||||||
2 | experience. The delegated tasks or duties shall be specific to | ||||||
3 | the
practice setting and shall be implemented and reviewed | ||||||
4 | under a written supervision agreement guidelines
established | ||||||
5 | by the physician or physician/physician assistant team. A
| ||||||
6 | physician assistant, acting as an agent of the physician, shall | ||||||
7 | be
permitted to transmit the supervising physician's orders as | ||||||
8 | determined by
the institution's by-laws, policies, procedures, | ||||||
9 | or job description within
which the physician/physician | ||||||
10 | assistant team practices. Physician
assistants shall practice | ||||||
11 | only in accordance with a written supervision agreement within | ||||||
12 | the established guidelines .
| ||||||
13 | 4. "Board" means the Medical Licensing Board
constituted | ||||||
14 | under the Medical Practice Act of 1987.
| ||||||
15 | 5. "Disciplinary Board" means the Medical Disciplinary | ||||||
16 | Board constituted
under the Medical Practice Act of 1987.
| ||||||
17 | 6. "Physician" means, for purposes of this Act, a person | ||||||
18 | licensed to
practice medicine in all its branches under the | ||||||
19 | Medical Practice Act of 1987.
| ||||||
20 | 7. "Supervising Physician" means, for the purposes of this | ||||||
21 | Act, the
primary supervising physician of a physician | ||||||
22 | assistant, who, within his
specialty and expertise may delegate | ||||||
23 | a variety of tasks and procedures to
the physician assistant. | ||||||
24 | Such tasks and procedures shall be delegated
in accordance with | ||||||
25 | a written supervision agreement within established guidelines . | ||||||
26 | The supervising physician maintains the
final responsibility |
| |||||||
| |||||||
1 | for the care of the patient and the performance of the
| ||||||
2 | physician assistant.
| ||||||
3 | 8. "Alternate supervising physician" means, for the | ||||||
4 | purpose of this Act,
any physician designated by the | ||||||
5 | supervising physician to provide
supervision in the event that | ||||||
6 | he or she is unable to provide that supervision. The Department | ||||||
7 | may further define "alternate supervising physician" by rule.
| ||||||
8 | The alternate supervising physicians shall maintain all | ||||||
9 | the same
responsibilities as the supervising physician. | ||||||
10 | Nothing in this Act shall
be construed as relieving any | ||||||
11 | physician of the professional or legal
responsibility for the | ||||||
12 | care and treatment of persons attended by him or by
physician | ||||||
13 | assistants under his supervision. Nothing in this Act shall be
| ||||||
14 | construed as to limit the reasonable number of alternate | ||||||
15 | supervising
physicians, provided they are designated by the | ||||||
16 | supervising physician. | ||||||
17 | 9. "Address of record" means the designated address | ||||||
18 | recorded by the Department in the applicant's or licensee's | ||||||
19 | application file or license file maintained by the Department's | ||||||
20 | licensure maintenance unit. It is the duty of the applicant or | ||||||
21 | licensee to inform the Department of any change of address, and | ||||||
22 | such changes must be made either through the Department's | ||||||
23 | website or by contacting the Department's licensure | ||||||
24 | maintenance unit.
| ||||||
25 | (Source: P.A. 95-703, eff. 12-31-07.)
|
| |||||||
| |||||||
1 | (225 ILCS 95/7.5)
| ||||||
2 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
3 | Sec. 7.5. Prescriptions ; written supervision agreements; | ||||||
4 | prescriptive authority . | ||||||
5 | (a) A written supervision agreement is required for all | ||||||
6 | physician assistants to practice in the State. | ||||||
7 | (1) A written supervision agreement shall describe the | ||||||
8 | working relationship of the physician assistant with the | ||||||
9 | supervising physician and shall authorize the categories | ||||||
10 | of care, treatment, or procedures to be performed by the | ||||||
11 | physician assistant.
The written supervision agreement | ||||||
12 | shall be defined to promote the exercise of professional | ||||||
13 | judgment by the physician assistant commensurate with his | ||||||
14 | or her education and experience. The services to be | ||||||
15 | provided by the physician assistant shall be services that | ||||||
16 | the supervising physician is authorized to and generally | ||||||
17 | provides to his or her patients in the normal course of his | ||||||
18 | or her clinical medical practice. The written supervision | ||||||
19 | agreement need not describe the exact steps that a | ||||||
20 | physician assistant must take with respect to each specific | ||||||
21 | condition, disease, or symptom but must specify which | ||||||
22 | authorized procedures require the presence of the | ||||||
23 | supervising physician as the procedures are being | ||||||
24 | performed. The supervision relationship under a written | ||||||
25 | supervision agreement shall not be construed to require the | ||||||
26 | personal presence of a physician at all times at the place |
| |||||||
| |||||||
1 | where services are rendered. Methods of communication | ||||||
2 | shall be available for consultation with the supervising | ||||||
3 | physician in person or by telecommunications in accordance | ||||||
4 | with established written guidelines as set forth in the | ||||||
5 | written supervision agreement. | ||||||
6 | (2) The written supervision agreement shall be | ||||||
7 | adequate if a physician does each of the following: | ||||||
8 | (A) Participates in the joint formulation and | ||||||
9 | joint approval of orders or guidelines with the | ||||||
10 | physician assistant and he or she periodically reviews | ||||||
11 | such orders and the services provided patients under | ||||||
12 | such orders in accordance with accepted standards of | ||||||
13 | medical practice and physician assistant practice. | ||||||
14 | (B) Meets in person with the physician assistant at | ||||||
15 | least once a month to provide supervision. | ||||||
16 | (3) A copy of the signed, written supervision agreement | ||||||
17 | must be available to the Department upon request from both | ||||||
18 | the physician assistant and the supervising physician. | ||||||
19 | (4) A physician assistant shall inform each | ||||||
20 | supervising physician of all written supervision | ||||||
21 | agreements he or she has signed and provide a copy of these | ||||||
22 | to any supervising physician upon request. | ||||||
23 | (b) A supervising physician may, but is not required to, | ||||||
24 | delegate prescriptive authority to a physician assistant as | ||||||
25 | part of a written supervision agreement. This authority may, | ||||||
26 | but is not required to, include prescription of, selection of, |
| |||||||
| |||||||
1 | orders for, administration of, storage of, acceptance of | ||||||
2 | samples of, and dispensing over the counter medications, legend | ||||||
3 | drugs, medical gases, and controlled substances categorized as | ||||||
4 | Schedule III through V controlled substances, as defined in | ||||||
5 | Article II of the Illinois Controlled Substances Act, and other | ||||||
6 | preparations, including, but not limited to, botanical and | ||||||
7 | herbal remedies. The supervising physician must have a valid, | ||||||
8 | current Illinois controlled substance license and federal | ||||||
9 | registration with the Drug Enforcement Agency to delegate the | ||||||
10 | authority to prescribe controlled substances. A supervising | ||||||
11 | physician may delegate
limited prescriptive authority to a | ||||||
12 | physician assistant.
This authority may, but is not required | ||||||
13 | to, include prescription and
dispensing of legend
drugs and | ||||||
14 | legend controlled substances categorized as Schedule III, IV, | ||||||
15 | or V
controlled substances, as defined in Article II of the | ||||||
16 | Illinois Controlled
Substances Act, as delegated in the written | ||||||
17 | guidelines required by this
Act. | ||||||
18 | (1) To prescribe Schedule III, IV, or V controlled | ||||||
19 | substances under this
Section, a physician assistant must | ||||||
20 | obtain a mid-level practitioner
controlled substances | ||||||
21 | license. Medication orders issued by a
physician
assistant | ||||||
22 | shall be reviewed
periodically by the supervising | ||||||
23 | physician. | ||||||
24 | (2) The supervising physician shall file
with the | ||||||
25 | Department notice of delegation of prescriptive authority | ||||||
26 | to a
physician assistant and
termination of delegation, |
| |||||||
| |||||||
1 | specifying the authority delegated or terminated.
Upon | ||||||
2 | receipt of this notice delegating authority to prescribe | ||||||
3 | Schedule III,
IV, or V controlled substances, the physician | ||||||
4 | assistant shall be eligible to
register for a mid-level | ||||||
5 | practitioner controlled substances license under
Section | ||||||
6 | 303.05 of the Illinois Controlled Substances Act.
Nothing | ||||||
7 | in this Act shall be construed to limit the delegation of | ||||||
8 | tasks or
duties by the supervising physician to a nurse or | ||||||
9 | other appropriately trained
personnel.
| ||||||
10 | (3) In addition to the requirements of subsection (b) | ||||||
11 | of this Section, a supervising physician may, but is not | ||||||
12 | required to, delegate authority to a physician assistant to | ||||||
13 | prescribe Schedule II controlled substances, if all of the | ||||||
14 | following conditions apply: | ||||||
15 | (A) No more than 5 Schedule II controlled | ||||||
16 | substances by oral dosage may be delegated. | ||||||
17 | (B) Any delegation must be controlled substances | ||||||
18 | that the supervising physician prescribes. | ||||||
19 | (C) Any prescription must be limited to no more | ||||||
20 | than a 30-day oral dosage, with any continuation | ||||||
21 | authorized only after prior approval of the | ||||||
22 | supervising physician. | ||||||
23 | (c) Nothing in this Act shall be construed to limit the | ||||||
24 | delegation of tasks or duties by a physician to a licensed | ||||||
25 | practical nurse, a registered professional nurse, or other | ||||||
26 | persons. The Department shall establish by rule the minimum |
| |||||||
| |||||||
1 | requirements for
written guidelines to be followed under this | ||||||
2 | Section.
| ||||||
3 | (Source: P.A. 90-116, eff. 7-14-97; 90-818, eff. 3-23-99 .)
| ||||||
4 | (225 ILCS 95/21) (from Ch. 111, par. 4621)
| ||||||
5 | (Section scheduled to be repealed on January 1, 2018)
| ||||||
6 | Sec. 21. Grounds for disciplinary action.
| ||||||
7 | (a) The Department may refuse to issue or to renew, or may
| ||||||
8 | revoke, suspend, place on probation, censure or reprimand, or | ||||||
9 | take other
disciplinary or non-disciplinary action with regard | ||||||
10 | to any license issued under this Act as the
Department may deem | ||||||
11 | proper, including the issuance of fines not to exceed
$10,000
| ||||||
12 | for each violation, for any one or combination of the following | ||||||
13 | causes:
| ||||||
14 | (1) Material misstatement in furnishing information to | ||||||
15 | the Department.
| ||||||
16 | (2) Violations of this Act, or the rules adopted under | ||||||
17 | this Act.
| ||||||
18 | (3) Conviction of or entry of a plea of guilty or nolo | ||||||
19 | contendere to any crime that is a felony under the laws of | ||||||
20 | the United States or any state or territory thereof
or that | ||||||
21 | is a misdemeanor
of which an essential element is
| ||||||
22 | dishonesty or
that
is directly related to the practice of | ||||||
23 | the
profession.
| ||||||
24 | (4) Making any misrepresentation for the purpose of | ||||||
25 | obtaining licenses.
|
| |||||||
| |||||||
1 | (5) Professional incompetence.
| ||||||
2 | (6) Aiding or assisting another person in violating any | ||||||
3 | provision of this
Act or its rules.
| ||||||
4 | (7) Failing, within 60 days, to provide information in | ||||||
5 | response to a
written request made by the Department.
| ||||||
6 | (8) Engaging in dishonorable, unethical, or | ||||||
7 | unprofessional conduct, as
defined by rule, of a character | ||||||
8 | likely to deceive, defraud, or harm the public.
| ||||||
9 | (9) Habitual or excessive use or addiction to alcohol, | ||||||
10 | narcotics,
stimulants, or any other chemical agent or drug | ||||||
11 | that results in a physician
assistant's inability to | ||||||
12 | practice with reasonable judgment, skill, or safety.
| ||||||
13 | (10) Discipline by another U.S. jurisdiction or | ||||||
14 | foreign nation, if at
least one of the grounds for | ||||||
15 | discipline is the same or substantially equivalent
to those | ||||||
16 | set forth in this Section.
| ||||||
17 | (11) Directly or indirectly giving to or receiving from | ||||||
18 | any person, firm,
corporation, partnership, or association | ||||||
19 | any fee, commission, rebate or
other form of compensation | ||||||
20 | for any professional services not actually or
personally | ||||||
21 | rendered.
| ||||||
22 | (12) A finding by the Disciplinary Board that the | ||||||
23 | licensee, after having
his or her license placed on | ||||||
24 | probationary status has violated the terms of
probation.
| ||||||
25 | (13) Abandonment of a patient.
| ||||||
26 | (14) Willfully making or filing false records or |
| |||||||
| |||||||
1 | reports in his or her
practice, including but not limited | ||||||
2 | to false records filed with state agencies
or departments.
| ||||||
3 | (15) Willfully failing to report an instance of | ||||||
4 | suspected child abuse or
neglect as required by the Abused | ||||||
5 | and Neglected Child Reporting Act.
| ||||||
6 | (16) Physical illness, or mental illness or impairment
| ||||||
7 | that results in the inability to practice the profession | ||||||
8 | with
reasonable judgment, skill, or safety, including, but | ||||||
9 | not limited to, deterioration through the aging process or | ||||||
10 | loss of motor skill.
| ||||||
11 | (17) Being named as a perpetrator in an indicated | ||||||
12 | report by the
Department of Children and Family Services | ||||||
13 | under the Abused and
Neglected Child Reporting Act, and | ||||||
14 | upon proof by clear and convincing evidence
that the | ||||||
15 | licensee has caused a child to be an abused child or | ||||||
16 | neglected child
as defined in the Abused and Neglected | ||||||
17 | Child Reporting Act.
| ||||||
18 | (18) (Blank).
| ||||||
19 | (19) Gross negligence
resulting in permanent injury or | ||||||
20 | death
of a patient.
| ||||||
21 | (20) Employment of fraud, deception or any unlawful | ||||||
22 | means in applying for
or securing a license as a physician | ||||||
23 | assistant.
| ||||||
24 | (21) Exceeding the authority delegated to him or her by | ||||||
25 | his or her
supervising physician in a written supervision | ||||||
26 | agreement guidelines established by the |
| |||||||
| |||||||
1 | physician/physician
assistant
team .
| ||||||
2 | (22) Immoral conduct in the commission of any act, such | ||||||
3 | as sexual abuse,
sexual misconduct or sexual exploitation | ||||||
4 | related to the licensee's practice.
| ||||||
5 | (23) Violation of the Health Care Worker Self-Referral | ||||||
6 | Act.
| ||||||
7 | (24) Practicing under a false or assumed name, except | ||||||
8 | as provided by law.
| ||||||
9 | (25) Making a false or misleading statement regarding | ||||||
10 | his or her skill or
the efficacy or value of the medicine, | ||||||
11 | treatment, or remedy prescribed by him
or her in the course | ||||||
12 | of treatment.
| ||||||
13 | (26) Allowing another person to use his or her license | ||||||
14 | to practice.
| ||||||
15 | (27) Prescribing, selling, administering, | ||||||
16 | distributing, giving, or
self-administering a drug | ||||||
17 | classified as a controlled substance (designated
product) | ||||||
18 | or narcotic for other than medically-accepted therapeutic | ||||||
19 | purposes.
| ||||||
20 | (28) Promotion of the sale of drugs, devices, | ||||||
21 | appliances, or goods
provided for a patient in a manner to | ||||||
22 | exploit the patient for financial gain.
| ||||||
23 | (29) A pattern of practice or other behavior that | ||||||
24 | demonstrates incapacity
or incompetence to practice under | ||||||
25 | this Act.
| ||||||
26 | (30) Violating State or federal laws or regulations |
| |||||||
| |||||||
1 | relating to controlled
substances or other legend drugs.
| ||||||
2 | (31) Exceeding the limited prescriptive authority | ||||||
3 | delegated by the
supervising physician or violating the | ||||||
4 | written supervision agreement guidelines delegating that
| ||||||
5 | authority.
| ||||||
6 | (32) Practicing without providing to the Department a | ||||||
7 | notice of
supervision or delegation of
prescriptive | ||||||
8 | authority.
| ||||||
9 | (b) The Department may, without a hearing, refuse to issue | ||||||
10 | or renew or may suspend the license of any
person who fails to | ||||||
11 | file a return, or to pay the tax, penalty or interest
shown in | ||||||
12 | a filed return, or to pay any final assessment of the tax,
| ||||||
13 | penalty, or interest as required by any tax Act administered by | ||||||
14 | the
Illinois Department of Revenue, until such time as the | ||||||
15 | requirements of any
such tax Act are satisfied.
| ||||||
16 | (c) The determination by a circuit court that a licensee is | ||||||
17 | subject to
involuntary admission or judicial admission as | ||||||
18 | provided in the Mental Health
and Developmental Disabilities | ||||||
19 | Code operates as an automatic suspension.
The
suspension will | ||||||
20 | end only upon a finding by a court that the patient is no
| ||||||
21 | longer subject to involuntary admission or judicial admission | ||||||
22 | and issues an
order so finding and discharging the patient, and | ||||||
23 | upon the
recommendation of
the Disciplinary Board to the | ||||||
24 | Secretary
that the licensee be allowed to resume
his or her | ||||||
25 | practice.
| ||||||
26 | (d) In enforcing this Section, the Department upon a |
| |||||||
| |||||||
1 | showing of a
possible
violation may compel an individual | ||||||
2 | licensed to practice under this Act, or
who has applied for | ||||||
3 | licensure under this Act, to submit
to a mental or physical | ||||||
4 | examination, or both, as required by and at the expense
of the | ||||||
5 | Department. The Department may order the examining physician to
| ||||||
6 | present
testimony concerning the mental or physical | ||||||
7 | examination of the licensee or
applicant. No information shall | ||||||
8 | be excluded by reason of any common law or
statutory privilege | ||||||
9 | relating to communications between the licensee or
applicant | ||||||
10 | and the examining physician. The examining
physicians
shall be | ||||||
11 | specifically designated by the Department.
The individual to be | ||||||
12 | examined may have, at his or her own expense, another
physician | ||||||
13 | of his or her choice present during all
aspects of this | ||||||
14 | examination. Failure of an individual to submit to a mental
or
| ||||||
15 | physical examination, when directed, shall be grounds for | ||||||
16 | suspension of his or
her
license until the individual submits | ||||||
17 | to the examination if the Department
finds,
after notice and | ||||||
18 | hearing, that the refusal to submit to the examination was
| ||||||
19 | without reasonable cause.
| ||||||
20 | If the Department finds an individual unable to practice | ||||||
21 | because of
the
reasons
set forth in this Section, the | ||||||
22 | Department may require that individual
to submit
to
care, | ||||||
23 | counseling, or treatment by physicians approved
or designated | ||||||
24 | by the Department, as a condition, term, or restriction
for | ||||||
25 | continued,
reinstated, or
renewed licensure to practice; or, in | ||||||
26 | lieu of care, counseling, or treatment,
the Department may file
|
| |||||||
| |||||||
1 | a complaint to immediately
suspend, revoke, or otherwise | ||||||
2 | discipline the license of the individual.
An individual whose
| ||||||
3 | license was granted, continued, reinstated, renewed, | ||||||
4 | disciplined, or supervised
subject to such terms, conditions, | ||||||
5 | or restrictions, and who fails to comply
with
such terms, | ||||||
6 | conditions, or restrictions, shall be referred to the Secretary
| ||||||
7 | for
a
determination as to whether the individual shall have his | ||||||
8 | or her license
suspended immediately, pending a hearing by the | ||||||
9 | Department.
| ||||||
10 | In instances in which the Secretary
immediately suspends a | ||||||
11 | person's license
under this Section, a hearing on that person's | ||||||
12 | license must be convened by
the Department within 30
days after | ||||||
13 | the suspension and completed without
appreciable
delay.
The | ||||||
14 | Department shall have the authority to review the subject
| ||||||
15 | individual's record of
treatment and counseling regarding the | ||||||
16 | impairment to the extent permitted by
applicable federal | ||||||
17 | statutes and regulations safeguarding the confidentiality of
| ||||||
18 | medical records.
| ||||||
19 | An individual licensed under this Act and affected under | ||||||
20 | this Section shall
be
afforded an opportunity to demonstrate to | ||||||
21 | the Department that he or
she can resume
practice in compliance | ||||||
22 | with acceptable and prevailing standards under the
provisions | ||||||
23 | of his or her license.
| ||||||
24 | (Source: P.A. 95-703, eff. 12-31-07.)
| ||||||
25 | Section 15. The Illinois Controlled Substances Act is |
| |||||||
| |||||||
1 | amended by changing Sections 102 and 303.05 as follows: | ||||||
2 | (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | ||||||
3 | Sec. 102. Definitions. As used in this Act, unless the | ||||||
4 | context
otherwise requires:
| ||||||
5 | (a) "Addict" means any person who habitually uses any drug, | ||||||
6 | chemical,
substance or dangerous drug other than alcohol so as | ||||||
7 | to endanger the public
morals, health, safety or welfare or who | ||||||
8 | is so far addicted to the use of a
dangerous drug or controlled | ||||||
9 | substance other than alcohol as to have lost
the power of self | ||||||
10 | control with reference to his addiction.
| ||||||
11 | (b) "Administer" means the direct application of a | ||||||
12 | controlled
substance, whether by injection, inhalation, | ||||||
13 | ingestion, or any other
means, to the body of a patient, | ||||||
14 | research subject, or animal (as
defined by the Humane | ||||||
15 | Euthanasia in Animal Shelters Act) by:
| ||||||
16 | (1) a practitioner (or, in his presence, by his | ||||||
17 | authorized agent),
| ||||||
18 | (2) the patient or research subject at the lawful | ||||||
19 | direction of the
practitioner, or
| ||||||
20 | (3) a euthanasia technician as defined by the Humane | ||||||
21 | Euthanasia in
Animal Shelters Act.
| ||||||
22 | (c) "Agent" means an authorized person who acts on behalf | ||||||
23 | of or at
the direction of a manufacturer, distributor, or | ||||||
24 | dispenser. It does not
include a common or contract carrier, | ||||||
25 | public warehouseman or employee of
the carrier or warehouseman.
|
| |||||||
| |||||||
1 | (c-1) "Anabolic Steroids" means any drug or hormonal | ||||||
2 | substance,
chemically and pharmacologically related to | ||||||
3 | testosterone (other than
estrogens, progestins, and | ||||||
4 | corticosteroids) that promotes muscle growth,
and includes:
| ||||||
5 | (i) boldenone,
| ||||||
6 | (ii) chlorotestosterone,
| ||||||
7 | (iii) chostebol,
| ||||||
8 | (iv) dehydrochlormethyltestosterone,
| ||||||
9 | (v) dihydrotestosterone,
| ||||||
10 | (vi) drostanolone,
| ||||||
11 | (vii) ethylestrenol,
| ||||||
12 | (viii) fluoxymesterone,
| ||||||
13 | (ix) formebulone,
| ||||||
14 | (x) mesterolone,
| ||||||
15 | (xi) methandienone,
| ||||||
16 | (xii) methandranone,
| ||||||
17 | (xiii) methandriol,
| ||||||
18 | (xiv) methandrostenolone,
| ||||||
19 | (xv) methenolone,
| ||||||
20 | (xvi) methyltestosterone,
| ||||||
21 | (xvii) mibolerone,
| ||||||
22 | (xviii) nandrolone,
| ||||||
23 | (xix) norethandrolone,
| ||||||
24 | (xx) oxandrolone,
| ||||||
25 | (xxi) oxymesterone,
| ||||||
26 | (xxii) oxymetholone,
|
| |||||||
| |||||||
1 | (xxiii) stanolone,
| ||||||
2 | (xxiv) stanozolol,
| ||||||
3 | (xxv) testolactone,
| ||||||
4 | (xxvi) testosterone,
| ||||||
5 | (xxvii) trenbolone, and
| ||||||
6 | (xxviii) any salt, ester, or isomer of a drug or | ||||||
7 | substance described
or listed in this paragraph, if | ||||||
8 | that salt, ester, or isomer promotes muscle
growth.
| ||||||
9 | Any person who is otherwise lawfully in possession of an | ||||||
10 | anabolic
steroid, or who otherwise lawfully manufactures, | ||||||
11 | distributes, dispenses,
delivers, or possesses with intent to | ||||||
12 | deliver an anabolic steroid, which
anabolic steroid is | ||||||
13 | expressly intended for and lawfully allowed to be
administered | ||||||
14 | through implants to livestock or other nonhuman species, and
| ||||||
15 | which is approved by the Secretary of Health and Human Services | ||||||
16 | for such
administration, and which the person intends to | ||||||
17 | administer or have
administered through such implants, shall | ||||||
18 | not be considered to be in
unauthorized possession or to | ||||||
19 | unlawfully manufacture, distribute, dispense,
deliver, or | ||||||
20 | possess with intent to deliver such anabolic steroid for
| ||||||
21 | purposes of this Act.
| ||||||
22 | (d) "Administration" means the Drug Enforcement | ||||||
23 | Administration,
United States Department of Justice, or its | ||||||
24 | successor agency.
| ||||||
25 | (e) "Control" means to add a drug or other substance, or | ||||||
26 | immediate
precursor, to a Schedule under Article II of this Act |
| |||||||
| |||||||
1 | whether by
transfer from another Schedule or otherwise.
| ||||||
2 | (f) "Controlled Substance" means a drug, substance, or | ||||||
3 | immediate
precursor in the Schedules of Article II of this Act.
| ||||||
4 | (g) "Counterfeit substance" means a controlled substance, | ||||||
5 | which, or
the container or labeling of which, without | ||||||
6 | authorization bears the
trademark, trade name, or other | ||||||
7 | identifying mark, imprint, number or
device, or any likeness | ||||||
8 | thereof, of a manufacturer, distributor, or
dispenser other | ||||||
9 | than the person who in fact manufactured, distributed,
or | ||||||
10 | dispensed the substance.
| ||||||
11 | (h) "Deliver" or "delivery" means the actual, constructive | ||||||
12 | or
attempted transfer of possession of a controlled substance, | ||||||
13 | with or
without consideration, whether or not there is an | ||||||
14 | agency relationship.
| ||||||
15 | (i) "Department" means the Illinois Department of Human | ||||||
16 | Services (as
successor to the Department of Alcoholism and | ||||||
17 | Substance Abuse) or its successor agency.
| ||||||
18 | (j) "Department of State Police" means the Department of | ||||||
19 | State
Police of the State of Illinois or its successor agency.
| ||||||
20 | (k) "Department of Corrections" means the Department of | ||||||
21 | Corrections
of the State of Illinois or its successor agency.
| ||||||
22 | (l) "Department of Professional Regulation" means the | ||||||
23 | Department
of Professional Regulation of the State of Illinois | ||||||
24 | or its successor agency.
| ||||||
25 | (m) "Depressant" or "stimulant substance" means:
| ||||||
26 | (1) a drug which contains any quantity of (i) |
| |||||||
| |||||||
1 | barbituric acid or
any of the salts of barbituric acid | ||||||
2 | which has been designated as habit
forming under section | ||||||
3 | 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 | ||||||
4 | U.S.C. 352 (d)); or
| ||||||
5 | (2) a drug which contains any quantity of (i) | ||||||
6 | amphetamine or
methamphetamine and any of their optical | ||||||
7 | isomers; (ii) any salt of
amphetamine or methamphetamine or | ||||||
8 | any salt of an optical isomer of
amphetamine; or (iii) any | ||||||
9 | substance which the Department, after
investigation, has | ||||||
10 | found to be, and by rule designated as, habit forming
| ||||||
11 | because of its depressant or stimulant effect on the | ||||||
12 | central nervous
system; or
| ||||||
13 | (3) lysergic acid diethylamide; or
| ||||||
14 | (4) any drug which contains any quantity of a substance | ||||||
15 | which the
Department, after investigation, has found to | ||||||
16 | have, and by rule
designated as having, a potential for | ||||||
17 | abuse because of its depressant or
stimulant effect on the | ||||||
18 | central nervous system or its hallucinogenic
effect.
| ||||||
19 | (n) (Blank).
| ||||||
20 | (o) "Director" means the Director of the Department of | ||||||
21 | State Police or
the Department of Professional Regulation or | ||||||
22 | his designated agents.
| ||||||
23 | (p) "Dispense" means to deliver a controlled substance to | ||||||
24 | an
ultimate user or research subject by or pursuant to the | ||||||
25 | lawful order of
a prescriber, including the prescribing, | ||||||
26 | administering, packaging,
labeling, or compounding necessary |
| |||||||
| |||||||
1 | to prepare the substance for that
delivery.
| ||||||
2 | (q) "Dispenser" means a practitioner who dispenses.
| ||||||
3 | (r) "Distribute" means to deliver, other than by | ||||||
4 | administering or
dispensing, a controlled substance.
| ||||||
5 | (s) "Distributor" means a person who distributes.
| ||||||
6 | (t) "Drug" means (1) substances recognized as drugs in the | ||||||
7 | official
United States Pharmacopoeia, Official Homeopathic | ||||||
8 | Pharmacopoeia of the
United States, or official National | ||||||
9 | Formulary, or any supplement to any
of them; (2) substances | ||||||
10 | intended for use in diagnosis, cure, mitigation,
treatment, or | ||||||
11 | prevention of disease in man or animals; (3) substances
(other | ||||||
12 | than food) intended to affect the structure of any function of
| ||||||
13 | the body of man or animals and (4) substances intended for use | ||||||
14 | as a
component of any article specified in clause (1), (2), or | ||||||
15 | (3) of this
subsection. It does not include devices or their | ||||||
16 | components, parts, or
accessories.
| ||||||
17 | (t-5) "Euthanasia agency" means
an entity certified by the | ||||||
18 | Department of Professional Regulation for the
purpose of animal | ||||||
19 | euthanasia that holds an animal control facility license or
| ||||||
20 | animal
shelter license under the Animal Welfare Act. A | ||||||
21 | euthanasia agency is
authorized to purchase, store, possess, | ||||||
22 | and utilize Schedule II nonnarcotic and
Schedule III | ||||||
23 | nonnarcotic drugs for the sole purpose of animal euthanasia.
| ||||||
24 | (t-10) "Euthanasia drugs" means Schedule II or Schedule III | ||||||
25 | substances
(nonnarcotic controlled substances) that are used | ||||||
26 | by a euthanasia agency for
the purpose of animal euthanasia.
|
| |||||||
| |||||||
1 | (u) "Good faith" means the prescribing or dispensing of a | ||||||
2 | controlled
substance by a practitioner in the regular course of | ||||||
3 | professional
treatment to or for any person who is under his | ||||||
4 | treatment for a
pathology or condition other than that | ||||||
5 | individual's physical or
psychological dependence upon or | ||||||
6 | addiction to a controlled substance,
except as provided herein: | ||||||
7 | and application of the term to a pharmacist
shall mean the | ||||||
8 | dispensing of a controlled substance pursuant to the
| ||||||
9 | prescriber's order which in the professional judgment of the | ||||||
10 | pharmacist
is lawful. The pharmacist shall be guided by | ||||||
11 | accepted professional
standards including, but not limited to | ||||||
12 | the following, in making the
judgment:
| ||||||
13 | (1) lack of consistency of doctor-patient | ||||||
14 | relationship,
| ||||||
15 | (2) frequency of prescriptions for same drug by one | ||||||
16 | prescriber for
large numbers of patients,
| ||||||
17 | (3) quantities beyond those normally prescribed,
| ||||||
18 | (4) unusual dosages,
| ||||||
19 | (5) unusual geographic distances between patient, | ||||||
20 | pharmacist and
prescriber,
| ||||||
21 | (6) consistent prescribing of habit-forming drugs.
| ||||||
22 | (u-1) "Home infusion services" means services provided by a | ||||||
23 | pharmacy in
compounding solutions for direct administration to | ||||||
24 | a patient in a private
residence, long-term care facility, or | ||||||
25 | hospice setting by means of parenteral,
intravenous, | ||||||
26 | intramuscular, subcutaneous, or intraspinal infusion.
|
| |||||||
| |||||||
1 | (v) "Immediate precursor" means a substance:
| ||||||
2 | (1) which the Department has found to be and by rule | ||||||
3 | designated as
being a principal compound used, or produced | ||||||
4 | primarily for use, in the
manufacture of a controlled | ||||||
5 | substance;
| ||||||
6 | (2) which is an immediate chemical intermediary used or | ||||||
7 | likely to
be used in the manufacture of such controlled | ||||||
8 | substance; and
| ||||||
9 | (3) the control of which is necessary to prevent, | ||||||
10 | curtail or limit
the manufacture of such controlled | ||||||
11 | substance.
| ||||||
12 | (w) "Instructional activities" means the acts of teaching, | ||||||
13 | educating
or instructing by practitioners using controlled | ||||||
14 | substances within
educational facilities approved by the State | ||||||
15 | Board of Education or
its successor agency.
| ||||||
16 | (x) "Local authorities" means a duly organized State, | ||||||
17 | County or
Municipal peace unit or police force.
| ||||||
18 | (y) "Look-alike substance" means a substance, other than a | ||||||
19 | controlled
substance which (1) by overall dosage unit | ||||||
20 | appearance, including shape,
color, size, markings or lack | ||||||
21 | thereof, taste, consistency, or any other
identifying physical | ||||||
22 | characteristic of the substance, would lead a reasonable
person | ||||||
23 | to believe that the substance is a controlled substance, or (2) | ||||||
24 | is
expressly or impliedly represented to be a controlled | ||||||
25 | substance or is
distributed under circumstances which would | ||||||
26 | lead a reasonable person to
believe that the substance is a |
| |||||||
| |||||||
1 | controlled substance. For the purpose of
determining whether | ||||||
2 | the representations made or the circumstances of the
| ||||||
3 | distribution would lead a reasonable person to believe the | ||||||
4 | substance to be
a controlled substance under this clause (2) of | ||||||
5 | subsection (y), the court or
other authority may consider the | ||||||
6 | following factors in addition to any other
factor that may be | ||||||
7 | relevant:
| ||||||
8 | (a) statements made by the owner or person in control | ||||||
9 | of the substance
concerning its nature, use or effect;
| ||||||
10 | (b) statements made to the buyer or recipient that the | ||||||
11 | substance may
be resold for profit;
| ||||||
12 | (c) whether the substance is packaged in a manner | ||||||
13 | normally used for the
illegal distribution of controlled | ||||||
14 | substances;
| ||||||
15 | (d) whether the distribution or attempted distribution | ||||||
16 | included an
exchange of or demand for money or other | ||||||
17 | property as consideration, and
whether the amount of the | ||||||
18 | consideration was substantially greater than the
| ||||||
19 | reasonable retail market value of the substance.
| ||||||
20 | Clause (1) of this subsection (y) shall not apply to a | ||||||
21 | noncontrolled
substance in its finished dosage form that was | ||||||
22 | initially introduced into
commerce prior to the initial | ||||||
23 | introduction into commerce of a controlled
substance in its | ||||||
24 | finished dosage form which it may substantially resemble.
| ||||||
25 | Nothing in this subsection (y) prohibits the dispensing or | ||||||
26 | distributing
of noncontrolled substances by persons authorized |
| |||||||
| |||||||
1 | to dispense and
distribute controlled substances under this | ||||||
2 | Act, provided that such action
would be deemed to be carried | ||||||
3 | out in good faith under subsection (u) if the
substances | ||||||
4 | involved were controlled substances.
| ||||||
5 | Nothing in this subsection (y) or in this Act prohibits the | ||||||
6 | manufacture,
preparation, propagation, compounding, | ||||||
7 | processing, packaging, advertising
or distribution of a drug or | ||||||
8 | drugs by any person registered pursuant to
Section 510 of the | ||||||
9 | Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
| ||||||
10 | (y-1) "Mail-order pharmacy" means a pharmacy that is | ||||||
11 | located in a state
of the United States, other than Illinois, | ||||||
12 | that delivers, dispenses or
distributes, through the United | ||||||
13 | States Postal Service or other common
carrier, to Illinois | ||||||
14 | residents, any substance which requires a prescription.
| ||||||
15 | (z) "Manufacture" means the production, preparation, | ||||||
16 | propagation,
compounding, conversion or processing of a | ||||||
17 | controlled substance other than methamphetamine, either
| ||||||
18 | directly or indirectly, by extraction from substances of | ||||||
19 | natural origin,
or independently by means of chemical | ||||||
20 | synthesis, or by a combination of
extraction and chemical | ||||||
21 | synthesis, and includes any packaging or
repackaging of the | ||||||
22 | substance or labeling of its container, except that
this term | ||||||
23 | does not include:
| ||||||
24 | (1) by an ultimate user, the preparation or compounding | ||||||
25 | of a
controlled substance for his own use; or
| ||||||
26 | (2) by a practitioner, or his authorized agent under |
| |||||||
| |||||||
1 | his
supervision, the preparation, compounding, packaging, | ||||||
2 | or labeling of a
controlled substance:
| ||||||
3 | (a) as an incident to his administering or | ||||||
4 | dispensing of a
controlled substance in the course of | ||||||
5 | his professional practice; or
| ||||||
6 | (b) as an incident to lawful research, teaching or | ||||||
7 | chemical
analysis and not for sale.
| ||||||
8 | (z-1) (Blank).
| ||||||
9 | (aa) "Narcotic drug" means any of the following, whether | ||||||
10 | produced
directly or indirectly by extraction from substances | ||||||
11 | of natural origin,
or independently by means of chemical | ||||||
12 | synthesis, or by a combination of
extraction and chemical | ||||||
13 | synthesis:
| ||||||
14 | (1) opium and opiate, and any salt, compound, | ||||||
15 | derivative, or
preparation of opium or opiate;
| ||||||
16 | (2) any salt, compound, isomer, derivative, or | ||||||
17 | preparation thereof
which is chemically equivalent or | ||||||
18 | identical with any of the substances
referred to in clause | ||||||
19 | (1), but not including the isoquinoline alkaloids
of opium;
| ||||||
20 | (3) opium poppy and poppy straw;
| ||||||
21 | (4) coca leaves and any salts, compound, isomer, salt | ||||||
22 | of an isomer,
derivative, or preparation of coca leaves | ||||||
23 | including cocaine or ecgonine,
and any salt, compound, | ||||||
24 | isomer, derivative, or preparation thereof which is
| ||||||
25 | chemically equivalent or identical with any of these | ||||||
26 | substances, but not
including decocainized coca leaves or |
| |||||||
| |||||||
1 | extractions of coca leaves which do
not contain cocaine or | ||||||
2 | ecgonine (for the purpose of this paragraph, the
term | ||||||
3 | "isomer" includes optical, positional and geometric | ||||||
4 | isomers).
| ||||||
5 | (bb) "Nurse" means a registered nurse licensed under the
| ||||||
6 | Nurse Practice Act.
| ||||||
7 | (cc) (Blank).
| ||||||
8 | (dd) "Opiate" means any substance having an addiction | ||||||
9 | forming or
addiction sustaining liability similar to morphine | ||||||
10 | or being capable of
conversion into a drug having addiction | ||||||
11 | forming or addiction sustaining
liability.
| ||||||
12 | (ee) "Opium poppy" means the plant of the species Papaver
| ||||||
13 | somniferum L., except its seeds.
| ||||||
14 | (ff) "Parole and Pardon Board" means the Parole and Pardon | ||||||
15 | Board of
the State of Illinois or its successor agency.
| ||||||
16 | (gg) "Person" means any individual, corporation, | ||||||
17 | mail-order pharmacy,
government or governmental subdivision or | ||||||
18 | agency, business trust, estate,
trust, partnership or | ||||||
19 | association, or any other entity.
| ||||||
20 | (hh) "Pharmacist" means any person who holds a license or | ||||||
21 | certificate of
registration as a registered pharmacist, a local | ||||||
22 | registered pharmacist
or a registered assistant pharmacist | ||||||
23 | under the Pharmacy Practice Act.
| ||||||
24 | (ii) "Pharmacy" means any store, ship or other place in | ||||||
25 | which
pharmacy is authorized to be practiced under the Pharmacy | ||||||
26 | Practice Act.
|
| |||||||
| |||||||
1 | (jj) "Poppy straw" means all parts, except the seeds, of | ||||||
2 | the opium
poppy, after mowing.
| ||||||
3 | (kk) "Practitioner" means a physician licensed to practice | ||||||
4 | medicine in all
its branches, dentist, optometrist, | ||||||
5 | podiatrist,
veterinarian, scientific investigator, pharmacist, | ||||||
6 | physician assistant,
advanced practice nurse,
licensed | ||||||
7 | practical
nurse, registered nurse, hospital, laboratory, or | ||||||
8 | pharmacy, or other
person licensed, registered, or otherwise | ||||||
9 | lawfully permitted by the
United States or this State to | ||||||
10 | distribute, dispense, conduct research
with respect to, | ||||||
11 | administer or use in teaching or chemical analysis, a
| ||||||
12 | controlled substance in the course of professional practice or | ||||||
13 | research.
| ||||||
14 | (ll) "Pre-printed prescription" means a written | ||||||
15 | prescription upon which
the designated drug has been indicated | ||||||
16 | prior to the time of issuance.
| ||||||
17 | (mm) "Prescriber" means a physician licensed to practice | ||||||
18 | medicine in all
its branches, dentist, optometrist, podiatrist | ||||||
19 | or
veterinarian who issues a prescription, a physician | ||||||
20 | assistant who
issues a
prescription for a Schedule III, IV, or | ||||||
21 | V controlled substance
in accordance
with Section 303.05 , a | ||||||
22 | written delegation, and a the written supervision agreement | ||||||
23 | guidelines required under Section 7.5
of the
Physician | ||||||
24 | Assistant Practice Act of 1987, or an advanced practice
nurse | ||||||
25 | with prescriptive authority delegated under Section 65-40 of | ||||||
26 | the Nurse Practice Act and in accordance with Section 303.05 , a |
| |||||||
| |||||||
1 | written delegation,
and a written
collaborative agreement | ||||||
2 | under Section 65-35 of the Nurse Practice Act.
| ||||||
3 | (nn) "Prescription" means a lawful written, facsimile, or | ||||||
4 | verbal order
of
a physician licensed to practice medicine in | ||||||
5 | all its branches,
dentist, podiatrist or veterinarian for any | ||||||
6 | controlled
substance, of an optometrist for a Schedule III, IV, | ||||||
7 | or V controlled substance in accordance with Section 15.1 of | ||||||
8 | the Illinois Optometric Practice Act of 1987, of a physician | ||||||
9 | assistant for a Schedule III, IV, or V
controlled substance
in | ||||||
10 | accordance with Section 303.05 , a written delegation, and a the | ||||||
11 | written supervision agreement guidelines required under
| ||||||
12 | Section 7.5 of the
Physician Assistant Practice Act of 1987, or | ||||||
13 | of an advanced practice
nurse with prescriptive authority | ||||||
14 | delegated under Section 65-40 of the Nurse Practice Act who | ||||||
15 | issues a prescription for a Schedule III, IV, or V
controlled | ||||||
16 | substance in accordance
with
Section 303.05 , a written | ||||||
17 | delegation, and a written collaborative agreement under | ||||||
18 | Section 65-35 of the Nurse Practice Act.
| ||||||
19 | (oo) "Production" or "produce" means manufacture, | ||||||
20 | planting,
cultivating, growing, or harvesting of a controlled | ||||||
21 | substance other than methamphetamine.
| ||||||
22 | (pp) "Registrant" means every person who is required to | ||||||
23 | register
under Section 302 of this Act.
| ||||||
24 | (qq) "Registry number" means the number assigned to each | ||||||
25 | person
authorized to handle controlled substances under the | ||||||
26 | laws of the United
States and of this State.
|
| |||||||
| |||||||
1 | (rr) "State" includes the State of Illinois and any state, | ||||||
2 | district,
commonwealth, territory, insular possession thereof, | ||||||
3 | and any area
subject to the legal authority of the United | ||||||
4 | States of America.
| ||||||
5 | (ss) "Ultimate user" means a person who lawfully possesses | ||||||
6 | a
controlled substance for his own use or for the use of a | ||||||
7 | member of his
household or for administering to an animal owned | ||||||
8 | by him or by a member
of his household.
| ||||||
9 | (Source: P.A. 94-556, eff. 9-11-05; 95-242, eff. 1-1-08; | ||||||
10 | 95-639, eff. 10-5-07; 95-689, eff. 10-29-07; 95-876, eff. | ||||||
11 | 8-21-08.)
| ||||||
12 | (720 ILCS 570/303.05)
| ||||||
13 | Sec. 303.05. Mid-level practitioner registration.
| ||||||
14 | (a) The Department of Financial and Professional | ||||||
15 | Regulation shall register licensed
physician assistants and | ||||||
16 | licensed advanced practice nurses to prescribe and
dispense | ||||||
17 | Schedule
III, IV, or V controlled substances under Section 303 | ||||||
18 | and euthanasia
agencies to purchase, store, or administer | ||||||
19 | animal euthanasia drugs under the
following circumstances:
| ||||||
20 | (1) with respect to physician assistants or advanced | ||||||
21 | practice nurses ,
| ||||||
22 | (A) the physician assistant or advanced practice | ||||||
23 | nurse has been
delegated
prescriptive authority to | ||||||
24 | prescribe any Schedule III through V controlled | ||||||
25 | substances by a physician licensed to practice |
| |||||||
| |||||||
1 | medicine in all its
branches in accordance with Section | ||||||
2 | 7.5 of the Physician Assistant Practice Act
of 1987 or | ||||||
3 | Section 65-40 of the Nurse Practice Act;
and
the (B) | ||||||
4 | the physician assistant or advanced practice nurse has
| ||||||
5 | completed the
appropriate application forms and has | ||||||
6 | paid the required fees as set by rule;
or
| ||||||
7 | (B) the physician assistant has been delegated
| ||||||
8 | authority by a supervising physician licensed to | ||||||
9 | practice medicine in all its branches to prescribe or | ||||||
10 | dispense Schedule II controlled substances through a | ||||||
11 | written delegation of authority and under the | ||||||
12 | following conditions: | ||||||
13 | (i) no more than 5 Schedule II controlled | ||||||
14 | substances by oral dosage may be delegated; | ||||||
15 | (ii) any delegation must be of controlled | ||||||
16 | substances prescribed by the supervising | ||||||
17 | physician; | ||||||
18 | (iii) all prescriptions must be limited to no | ||||||
19 | more than a 30-day oral dosage, with any | ||||||
20 | continuation authorized only after prior approval | ||||||
21 | of the supervising physician; | ||||||
22 | (iv) the physician assistant must discuss the | ||||||
23 | condition of any patients for whom a controlled | ||||||
24 | substance is prescribed monthly with the | ||||||
25 | delegating physician; and | ||||||
26 | (v) the physician assistant must have |
| |||||||
| |||||||
1 | completed the appropriate application forms and | ||||||
2 | paid the required fees as set by rule; and | ||||||
3 | (2) with respect to advanced practice nurses, | ||||||
4 | (A) the advanced practice nurse has been delegated
| ||||||
5 | authority to prescribe any Schedule III through V | ||||||
6 | controlled substances by a physician licensed to | ||||||
7 | practice medicine in all its branches or a podiatrist | ||||||
8 | in accordance with Section 65-40 of the Nurse Practice
| ||||||
9 | Act. The advanced practice nurse has completed the
| ||||||
10 | appropriate application forms and has paid the | ||||||
11 | required
fees as set by rule; or | ||||||
12 | (B) the advanced practice nurse has been delegated
| ||||||
13 | authority by a collaborating physician licensed to | ||||||
14 | practice medicine in all its branches to prescribe or | ||||||
15 | dispense Schedule II controlled substances through a | ||||||
16 | written delegation of authority and under the | ||||||
17 | following conditions: | ||||||
18 | (i) no more than 5 Schedule II controlled | ||||||
19 | substances by oral dosage may be delegated; | ||||||
20 | (ii) any delegation must be of controlled | ||||||
21 | substances prescribed by the collaborating | ||||||
22 | physician; | ||||||
23 | (iii) all prescriptions must be limited to no | ||||||
24 | more than a 30-day oral dosage, with any | ||||||
25 | continuation authorized only after prior approval | ||||||
26 | of the collaborating physician; |
| |||||||
| |||||||
1 | (iv) the advanced practice nurse must discuss | ||||||
2 | the condition of any patients for whom a controlled | ||||||
3 | substance is prescribed monthly with the | ||||||
4 | delegating physician; and | ||||||
5 | (v) the advanced practice nurse must have | ||||||
6 | completed the appropriate application forms and | ||||||
7 | paid the required fees as set by rule; or | ||||||
8 | (3) (2) with respect to animal euthanasia agencies, the | ||||||
9 | euthanasia agency has
obtained a license from the | ||||||
10 | Department of
Professional Regulation and obtained a | ||||||
11 | registration number from the
Department.
| ||||||
12 | (b) The mid-level practitioner shall only be licensed to | ||||||
13 | prescribe those
schedules of controlled substances for which a | ||||||
14 | licensed physician or licensed podiatrist has delegated
| ||||||
15 | prescriptive authority, except that an animal a euthanasia | ||||||
16 | agency does not have any
prescriptive authority.
A physician | ||||||
17 | assistant and an advanced practice nurse are prohibited from | ||||||
18 | prescribing medications and controlled substances not set | ||||||
19 | forth in the required written delegation of authority.
| ||||||
20 | (c) Upon completion of all registration requirements, | ||||||
21 | physician
assistants, advanced practice nurses, and animal | ||||||
22 | euthanasia agencies shall be issued a
mid-level practitioner
| ||||||
23 | controlled substances license for Illinois.
| ||||||
24 | (Source: P.A. 95-639, eff. 10-5-07.)
| ||||||
25 | Section 99. Effective date. This Act takes effect upon | ||||||
26 | becoming law. |